Identifying and Characterizing Preclinical MS

Part of paid clinical trials in North Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT05787795
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • biological samples — OTHER
    blood draw, oral swab, optional stool samples, spinal fluid sample, fat biopsy, tonsil biopsy, lymph node tissue sample, MRI

Study Details

The purpose of this research study is to try and identify risk factors and biologic changes that suggest that someone may go on to develop multiple sclerosis before a person has shown any symptoms of the disease.

Key Dates

First listed
Mar 28, 2023
Start date
Jun 21, 2022
Status verified
Aug 2026
Primary completion
Jun 30, 2032
Completion
Jun 30, 2033

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

To build a machine learning model of risk prediction [ Time Frame: ongoing prospective study ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Yale UniversityNorth HavenConnecticut06473
Cynthia Marques
[email protected]
203-287-6100
Erin Longbrake, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in North Haven, CT

Nationwide
Multiple sclerosis trialsNeurology trialsBrain disorders trialsAutoimmune disease trials
By condition
Multiple sclerosis
By specialty
NeurologyBrain disordersAutoimmune disease
By research site
Yale University· North Haven, CT

Related Studies